id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
anesthj-66	Erlinger, PhD, CRNA, Lisa; Monk, MD, MS, Terri; McAfee, MD, Steven	The Safety of Glucagon use during ERCP in Diabetic Patients with Renal Insufficiency: A Case Discussion and Review of Literature	2018	4	.pdf	application/pdf	2535	166	48	L-Hyoscyamine is associated with peri- procedural adverse effects including nausea and vomiting and has not been shown to decrease the amount of glucagon patients receive.11,16 Each counterbalances blood glucose levels to keep the body within the normal therapeutic range.	cache/anesthj-66.pdf	txt/anesthj-66.txt